Bioeutectics key facts
as of Oct 2026- Developer of natural and sustainable solvents designed to replace petrochemicals in industrial processes.
- Bioeutectics is valued at approximately $13.0M as of Oct 2026 (last reported valuation).
- It has raised $4.8M; the latest was Accelerator/Incubator in Oct 2025.
- Notable investors include MassChallenge, SOSV, Endless Frontier Labs, IndieBio, Atento Capital — 16 tracked in total.
- Status: Privately Held (backing).
Bioeutectics's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·The complete investor list: 16 names
- ·Watch Bioeutectics: the Monday email on marks, rounds and moves
Bioeutectics funding rounds
No funding rounds for Bioeutectics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Bioeutectics
16+Bioeutectics valuation
Bioeutectics's last reported valuation was $13 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
Bioeutectics investors
16 investors are on record for Bioeutectics, including MassChallenge, SOSV, Endless Frontier Labs and IndieBio.
About Bioeutectics
Developer of natural and sustainable solvents designed to replace petrochemicals in industrial processes. The company offers bio-sourced eutectic solvents made from natural acids, amino acids, alcohols, and sugars, allowing the personal care, food ingredients, agrotech, and greentech industries to adopt environmentally friendly, biodegradable alternatives, and aims to replace petrochemical solvents with bio-solvents, enabling clients to access sustainable products and enhance functionality.
- Sector
- Materials and Resources
- HQ
- Tulsa, OK, United States
- Founded
- 2021
- Employees
- 14
- Website
- bioeutectics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.